Eversept Partners LP Increases Position in HCA Healthcare, Inc. (NYSE:HCA)

Eversept Partners LP increased its stake in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 36.2% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 175,808 shares of the company's stock after purchasing an additional 46,724 shares during the quarter. HCA Healthcare accounts for 4.7% of Eversept Partners LP's investment portfolio, making the stock its 5th largest position. Eversept Partners LP owned approximately 0.07% of HCA Healthcare worth $52,769,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in HCA. Whipplewood Advisors LLC purchased a new position in HCA Healthcare in the 4th quarter valued at approximately $31,000. Tidemark LLC acquired a new position in shares of HCA Healthcare during the 4th quarter worth $36,000. Activest Wealth Management grew its stake in HCA Healthcare by 1,250.0% in the 4th quarter. Activest Wealth Management now owns 135 shares of the company's stock valued at $40,000 after acquiring an additional 125 shares during the last quarter. Pinnacle Bancorp Inc. raised its position in HCA Healthcare by 50.0% during the fourth quarter. Pinnacle Bancorp Inc. now owns 150 shares of the company's stock worth $45,000 after acquiring an additional 50 shares during the last quarter. Finally, Eastern Bank purchased a new position in shares of HCA Healthcare during the 4th quarter worth approximately $62,000. 62.73% of the stock is currently owned by institutional investors and hedge funds.

HCA Healthcare Stock Down 4.0 %

NYSE HCA traded down $13.72 during trading hours on Friday, reaching $327.69. 2,803,570 shares of the company traded hands, compared to its average volume of 1,398,028. The stock has a market capitalization of $80.68 billion, a PE ratio of 14.92, a PEG ratio of 1.10 and a beta of 1.48. The company has a 50 day moving average of $329.61 and a two-hundred day moving average of $332.87. The company has a current ratio of 1.08, a quick ratio of 0.97 and a debt-to-equity ratio of 69.07. HCA Healthcare, Inc. has a 12 month low of $289.98 and a 12 month high of $417.14.

HCA Healthcare (NYSE:HCA - Get Free Report) last announced its quarterly earnings data on Friday, April 25th. The company reported $6.45 earnings per share (EPS) for the quarter, beating the consensus estimate of $5.77 by $0.68. The firm had revenue of $18.32 billion for the quarter, compared to analysts' expectations of $18.26 billion. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. During the same quarter in the prior year, the firm posted $5.36 earnings per share. As a group, equities analysts expect that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Monday, June 30th. Shareholders of record on Monday, June 16th will be issued a $0.72 dividend. This represents a $2.88 dividend on an annualized basis and a yield of 0.88%. HCA Healthcare's dividend payout ratio is currently 13.11%.

Wall Street Analyst Weigh In

Several research firms have weighed in on HCA. Truist Financial dropped their price target on HCA Healthcare from $430.00 to $390.00 and set a "buy" rating for the company in a research report on Monday, January 6th. Bank of America decreased their target price on shares of HCA Healthcare from $380.00 to $370.00 and set a "buy" rating on the stock in a research report on Monday, January 27th. KeyCorp decreased their price objective on HCA Healthcare from $420.00 to $370.00 and set an "overweight" rating on the stock in a report on Tuesday, January 7th. Guggenheim assumed coverage on shares of HCA Healthcare in a research report on Wednesday, April 9th. They set a "neutral" rating for the company. Finally, Barclays decreased their target price on HCA Healthcare from $392.00 to $366.00 and set an "overweight" rating for the company in a report on Monday, January 27th. One equities research analyst has rated the stock with a sell rating, seven have issued a hold rating, eleven have assigned a buy rating and one has given a strong buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $381.67.

Insider Transactions at HCA Healthcare

In related news, SVP Jennifer Berres sold 9,533 shares of HCA Healthcare stock in a transaction dated Friday, February 14th. The shares were sold at an average price of $322.59, for a total value of $3,075,250.47. Following the sale, the senior vice president now directly owns 15,412 shares in the company, valued at $4,971,757.08. This trade represents a 38.22 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Insiders own 1.30% of the company's stock.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.